Navigation Links
AFFiRiS Begins Development of a Parkinson's Vaccine
Date:12/11/2008

VIENNA, Austria, December 11 /PRNewswire/ -- AFFiRiS has started pre-clinical development of a Parkinson's vaccine. The vaccine, known as PD01, can be used to target a specific protein that is closely associated with the causes of this degenerative neurological disease. Excellent product candidates from discovery studies have prompted the company to file a patent application and proceed immediately with development. Similarly positive results from external assessments impelled the Austrian Research Promotion Agency (FFG) to provide considerable financial funding for the project. The vaccine is based on the company's AFFITOME technology, which, among other things, has already been used to develop two Alzheimer's vaccines, which are currently both in phase I clinical testing.

AFFiRiS, based in Vienna, Austria, today announced the start of the pre-clinical development of its first Parkinson's vaccine PD01. The vaccine will be investigated for efficacy ("proof of concept") in Parkinson models. On successful conclusion of this preclinical evaluation, initial clinical testing could start in 2010/11. The Parkinson's vaccine specifically targets the alpha-synuclein (alpha-syn) protein, which is considered to be a key contributory element in Parkinson's disease.

Although all details of the disease are not yet fully understood, there is clear scientific evidence that the concentration and enrichment of alpha-syn in the brain are contributing factors in the progression of Parkinson's disease. Therefore, reducing the alpha-syn burden in the brain should have a positive impact on the course of the disease - a hypothesis that was recently confirmed by the results of U.S. researchers working on animal models.

The Parkinson's vaccine from AFFiRiS has been developed to delivery efficacy in combination with an excellent safety profile, as Dr. Walter Schmidt, CEO of AFFiRiS, explains: "Alpha-syn is an attractive targ
'/>"/>

SOURCE AFFiRiS GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AFFiRiS: Milestone Reached in Clinical Trial of Alzheimers Vaccine
2. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
5. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
6. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
7. Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
8. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
9. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015  Sangamo BioSciences, Inc. ... Nichol , M.B., Ch.B., Sangamo,s executive vice president, research ... of Sangamo,s ZFP Therapeutic ® development programs and ... ET on Tuesday, August 11, 2015, at the 2015 ... in New York, NY . ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 ... ) has announced the addition of the ... Patient Comfort and Operational Efficiency, with Growth Driven ... "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" discusses the market, ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ... million and $18.9 million for the three and six ... net loss of $12.1 million and $43.4 million for ... results were driven primarily by the more than $90 ... related to the upfront payment from Bayer to license  ...
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... Nov. 5, 2009 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 ... Foletta, senior vice president of finance and chief financial officer ... The audio portion of the presentation will be webcast and ...
... ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced third ... Third Quarter Vs Prior Quarter, ... 2008 Change 3Q,09 2Q,09 Change, ... ----- ------ ------ ----- ------ ------, Revenue ...
Cached Medicine Technology:Symmetry Medical Reports Third Quarter 2009 Financial Results 2Symmetry Medical Reports Third Quarter 2009 Financial Results 3Symmetry Medical Reports Third Quarter 2009 Financial Results 4Symmetry Medical Reports Third Quarter 2009 Financial Results 5Symmetry Medical Reports Third Quarter 2009 Financial Results 6Symmetry Medical Reports Third Quarter 2009 Financial Results 7Symmetry Medical Reports Third Quarter 2009 Financial Results 8
(Date:8/5/2015)... , ... August 05, 2015 , ... Social Security benefits ... participating in a new survey by The Senior Citizens League (TSCL). The ... trouble for an estimated 31 million Social Security beneficiaries age 65 and older, says ...
(Date:8/5/2015)... ... ... Stelari introduces their new collection, The Earth’s Song, inspired by the Australian ... Song. Combining fashion and activewear, Stelari’s new collection let’s you take your bohemian chic ... collection is sure to make the spirit seeker swoon with prints as meaningful as ...
(Date:8/5/2015)... Palm Coast, Florida (PRWEB) , ... August 05, 2015 , ... ... Inc (CEC) is excited to announce that it has hired Su Barnwell as ... medical education program and faculty management. From 1999 to 2015 she worked for Primary ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... HealthyYOU Vending ... Summer” campaign by the City & County of San Francisco are representative of ... Edwin M. Lee recently approved a measure from the City and County of San ...
(Date:8/5/2015)... ... 2015 , ... Over 6,500 athletes from 177 nations recently descended upon the ... Olympics World Games 2015 (July 25 to August 2). , Officially opened by First ... Angeles since the 1984 Olympics, and the Los Angeles Coliseum was once again filled ...
Breaking Medicine News(10 mins):Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 2Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 3Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 2Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 3Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 2Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 3
... A new device makes detection more easier. A combined ... than the conventional method. It is notoriously difficult to ... because the tissue is dense and so it's not ... normal areas. Doctors at the University of Texas now ...
... Cancer Institute in Texas, they have found a new place ... even in the face of powerful drug therapies.Dr. George N. ... Texas, //found that their findings show a type of NK ... could be infected by HIV. ,Not only do these ...
... inhibitor ramipril, used for the treatment of hypertension, can ... thereby lowering the risk of stroke and myocardial infarction ... Heat Outcome Prevention Evaluation (HOPE) study showed the drug ... broad range of patients – those with normal or ...
... team of scientists have successfully transplanted cultured stem cells ... light to the people who nearly lost their sight ... all 33 patients who suffered from conditions such as ... causing damage to the part of the eye called ...
... in France say that the distorting spectacles can help ... They think that the spectacles reset the patient's mental ... a long-lasting cure for some postural problems.// , People ... may suffer paralysis down their left side and can ...
... used gene therapy to restore sight to animals with ... scientists led by Jean Bennett, at the University of ... experiment involved dogs with Leber congenital amaurosis (LCA), a ... for which there is no treatment.// ,The disease ...
Cached Medicine News:Health News:A ray of light on Cardiology 2
... power table has everything that you need ... new AIT-15 offers 20 mm of additional ... and locking castors to secure the table. ... for most any application. Use a double ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... Topcon offers an all-metal Trial Frame ... features a practical screw-thread design that extends ... allowing for easy replacement of springs and ... the frame snugly yet comfortably on the ...
Inquire...
Medicine Products: